Financial reports
20-F
2023 FY
Annual report (foreign)
12 Mar 24
20-F
2022 FY
Annual report (foreign)
3 Mar 23
20-F
2021 FY
Annual report (foreign)
3 Mar 22
20-F
2020 FY
Annual report (foreign)
5 Mar 21
20-F
2019 FY
Annual report (foreign)
6 Mar 20
20-F
2018 FY
Annual report (foreign)
15 Mar 19
20-F
2017 FY
Annual report (foreign)
19 Mar 18
20-F
2016 FY
Annual report (foreign)
28 Mar 17
20-F
2015 FY
Annual report (foreign)
24 Mar 16
20-F
2014 FY
Annual report (foreign)
20 Mar 15
Current reports
6-K
Notice of Annual General Meeting
12 Apr 24
6-K
Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA
11 Apr 24
6-K
Oncolytics Biotech® to Participate in a Panel Presentation at Canaccord Genuity’s Horizons in Oncology Virtual Conference
2 Apr 24
6-K
Oncolytics Biotech® Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
7 Mar 24
6-K
Oncolytics Biotech® Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN
5 Mar 24
6-K
Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights
4 Mar 24
6-K
Oncolytics Biotech® Announces Presentation at the Cancer Advocacy Group of Louisiana’s 3rd Annual NeauxCancer Conference
28 Feb 24
6-K
Current report (foreign)
14 Feb 24
6-K
Oncolytics Biotech® Appoints Patricia S. Andrews to its Board of Directors
9 Jan 24
6-K
Oncolytics Biotech® Recaps 2023 Accomplishments, Provides Outlook for 2024
4 Jan 24
Registration and prospectus
SUPPL
Supplemental materials (foreign)
17 Jun 22
SUPPL
Supplemental materials (foreign)
17 Jun 22
F-10/A
Registration of securities (Canada) (amended)
16 Jun 22
F-X
Appointment of agent for service of process by issuers registering securities
10 Jun 22
F-10
Registration of securities (Canada)
9 Jun 22
SUPPL
Supplemental materials (foreign)
5 Mar 21
SUPPL
Supplemental materials (foreign)
4 Dec 20
SUPPL
Supplemental materials (foreign)
25 Jun 20
SUPPL
Supplemental materials (foreign)
16 Jun 20
F-10/A
Registration of securities (Canada) (amended)
12 Jun 20
Proxies
No filings
Other
EFFECT
Notice of effectiveness
21 Jun 22
EFFECT
Notice of effectiveness
16 Jun 20
CT ORDER
Confidential treatment order
5 Jun 18
CERT
Certification of approval for exchange listing
31 May 18
EFFECT
Notice of effectiveness
8 May 18
UPLOAD
Letter from SEC
1 Nov 16
CORRESP
Correspondence with SEC
14 Oct 16
UPLOAD
Letter from SEC
30 Sep 16
EFFECT
Notice of effectiveness
4 Aug 14
EFFECT
Notice of effectiveness
9 Jul 12